-
1 Comment
Dishman Carbogen Amcis Limited is currently in a long term uptrend where the price is trading 34.2% above its 200 day moving average.
From a valuation standpoint, the stock is 81.2% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 0.9.
Dishman Carbogen Amcis Limited's total revenue sank by 13.6% to $5B since the same quarter in the previous year.
Its net income has dropped by 148.9% to $-161M since the same quarter in the previous year.
Finally, its free cash flow grew by 2.3% to $2B since the same quarter in the previous year.
Based on the above factors, Dishman Carbogen Amcis Limited gets an overall score of 3/5.
| ISIN | INE385W01011 |
|---|---|
| Sector | Healthcare |
| Industry | Biotechnology |
| Exchange | NSE |
| CurrencyCode | INR |
| Target Price | 165 |
|---|---|
| Beta | 0.9 |
| Market Cap | 33B |
| PE Ratio | None |
| Dividend Yield | None |
Dishman Carbogen Amcis Limited provides contract research and manufacturing services for the pharmaceutical, healthcare, and bio-technology industries worldwide. The company operates through Contract Research and Manufacturing Services and Marketable Molecules segments. It also manufactures and supplies bulk drugs, active pharmaceutical ingredients (APIs), and general and highly potent APIs; specialty chemicals comprising intermediates, fine chemicals, phosphoranes, solid quaternary ammonium compounds, wittig reagents, and various pharmaceutical and cosmetic-related products; vitamin D products and its analogues; hand and body wash, sanitizers, and antiseptics; and phase transfer catalysts, soft gel capsules, disinfectant formulations, cholesterol, lanolin-related products, and liquid and lyophilized sterile injectables. The company was founded in 1983 and is headquartered in Ahmedabad, India. Dishman Carbogen Amcis Limited is a subsidiary of Adimans Technologies LLP.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for DCAL.NSE using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025
